- Home
- DBRG vs AAPG Comparison
DBRG vs AAPG Comparison
Compare DBRG & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBRG
- AAPG
- Stock Information
- Founded
- DBRG 1991
- AAPG 2009
- Country
- DBRG United States
- AAPG China
- Employees
- DBRG N/A
- AAPG N/A
- Industry
- DBRG Real Estate Investment Trusts
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- DBRG Real Estate
- AAPG Health Care
- Exchange
- DBRG Nasdaq
- AAPG Nasdaq
- Market Cap
- DBRG 1.9B
- AAPG 2.2B
- IPO Year
- DBRG 2009
- AAPG 2025
- Fundamental
- Price
- DBRG $11.06
- AAPG $24.40
- Analyst Decision
- DBRG Strong Buy
- AAPG Buy
- Analyst Count
- DBRG 9
- AAPG 1
- Target Price
- DBRG $16.28
- AAPG N/A
- AVG Volume (30 Days)
- DBRG 3.5M
- AAPG 14.1K
- Earning Date
- DBRG 05-01-2025
- AAPG 06-10-2025
- Dividend Yield
- DBRG 0.36%
- AAPG N/A
- EPS Growth
- DBRG N/A
- AAPG N/A
- EPS
- DBRG 0.32
- AAPG N/A
- Revenue
- DBRG $566,324,000.00
- AAPG $134,352,180.00
- Revenue This Year
- DBRG N/A
- AAPG N/A
- Revenue Next Year
- DBRG $19.16
- AAPG $389.09
- P/E Ratio
- DBRG $29.57
- AAPG N/A
- Revenue Growth
- DBRG N/A
- AAPG 341.77
- 52 Week Low
- DBRG $6.41
- AAPG $16.50
- 52 Week High
- DBRG $17.33
- AAPG $26.55
- Technical
- Relative Strength Index (RSI)
- DBRG 62.35
- AAPG N/A
- Support Level
- DBRG $10.66
- AAPG N/A
- Resistance Level
- DBRG $11.59
- AAPG N/A
- Average True Range (ATR)
- DBRG 0.59
- AAPG 0.00
- MACD
- DBRG 0.03
- AAPG 0.00
- Stochastic Oscillator
- DBRG 65.20
- AAPG 0.00
About DBRG DigitalBridge Group Inc.
DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.